Literature DB >> 21119723

Trial watch: targeting IL-17A shows broad promise in autoimmune diseases.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21119723     DOI： 10.1038/nrd3327

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Authors:  Wolfgang Hueber; Dhavalkumar D Patel; Thaddeus Dryja; Andrew M Wright; Irina Koroleva; Gerard Bruin; Christian Antoni; Zoe Draelos; Michael H Gold; Patrick Durez; Paul P Tak; Juan J Gomez-Reino; C Stephen Foster; Rosa Y Kim; C Michael Samson; Naomi S Falk; David S Chu; David Callanan; Quan Dong Nguyen; Kristine Rose; Asifa Haider; Franco Di Padova
Journal:  Sci Transl Med       Date:  2010-10-06       Impact factor: 17.956
  1 in total
  2 in total

1.  Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations.

Authors:  Abhirup Mandal; Ninad Kumbhojkar; Charles Reilly; Vimisha Dharamdasani; Anvay Ukidve; Donald E Ingber; Samir Mitragotri
Journal:  Sci Adv       Date:  2020-07-22       Impact factor: 14.136

2.  Immunometabolic function of the transcription cofactor VGLL3 provides an evolutionary rationale for sexual dimorphism in autoimmunity.

Authors:  Adam Pagenkopf; Yun Liang
Journal:  FEBS Lett       Date:  2020-09-04       Impact factor: 4.124
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.